secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tectonic Therapeutic, Inc. (TECX)
CIK:        0001681087
Form:       8-K
Filed at:   2023-06-09T23:59:59+00:00
Accession:  0001140361-23-029124
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

AVROBIO approves $250K in transaction bonuses for CEO and CTO tied to cystinosis program sale
--------------------------------------------------------------------------------

- Transaction bonuses of $150k for President/Interim CEO/CFO Erik Ostrowski and $100k for CTO Azadeh Golipour, payable in three installments after Asset Sale closing.
- Bonuses contingent on closing of previously announced sale of cystinosis gene therapy program; forfeiture if resignation/termination before payment.
- Stockholders elected directors Ian Clark and Annalisa Jenkins as Class II directors for term until 2026 annual meeting.
- Ratification of Ernst & Young as independent auditor for FY2023 with over 34 million votes for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1681087/000114036123029124/0001140361-23-029124-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1681087/000114036123029124/brhc20054224_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-029124

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer